Research
Metabolic adaptation
Sitagliptin elicited modest glycemic improvements without substantial alterations in lipid composition.
Sitagliptin may be less effective than semaglutide for lipid management in T2DM patients.
StrongSupportsmedium confidence
Conversely, sitagliptin elicited modest glycemic improvements without substantial alterations in lipid composition.
Why this rating
Based on the randomized trial design.
Source
Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study
László Imre Tóth et al. · International Journal of Molecular Sciences · 2025
rct · n=34Cited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →